Ralf Schmid is the founder of F2G. F2G has raised $100M in total funding. Latest round: Growth. Backed by Novo Holdings, Forbion, Advent Life Sciences.
Ralf Schmid is the Chief Financial Officer of F2G, bringing over 20 years of experience in M&A, licensing, and public and private market transactions. He joined F2G in 2016 from Nabriva Therapeutics AG, where he played a key role in the company going public on Nasdaq in 2015.
Full founder directory · Investor directory · Company funding database · Fundraising library